Sciatic neuropathy case study: 4-centimeter tumor discovered on sciatic nerve
The patient A 64-year-old woman tripped after “missing a step,” fracturing her left tibial plateau and resulting in deformity of the joint. This was managed conservatively, with a leg brace removing weight from the extremity. [...]
View more
Updated information on lecanemab infusions for mild cognitive impairment and Alzheimer’s
In 2023, the Food and Drug Administration (FDA) approved lecanemab (brand name Leqembi) for the treatment of Alzheimer’s disease. Lecanemab is the first widely used medication in a new class of anti-amyloid agents for the […]
View more
Christopher P. Rhyne, M.D., headache medicine specialist, has joined Norton Neuroscience Institute
Christopher P. Rhyne, M.D., is a headache medicine specialist at Norton Neuroscience Institute. He earned his medical degree from Windsor University School of Medicine, St. Kitts, West Indies. He completed his residency in family medicine […]
View more
Diagnosis and treatment for trigeminal neuralgia
The initial evaluation for trigeminal neuralgia is typically in primary care, but patients frequently also present to dental and ear, nose and throat settings, according to Brian M. Plato, D.O., a neurologist and headache specialist [...]
View more
Shawn W. Adams, M.D., joins Norton Leatherman Spine
After completing a pair of spinal fellowships in the latest surgical techniques and technologies, Shawn W. Adams, M.D., has joined Norton Leatherman Spine and Norton Neuroscience Institute. Dr. Adams’ fellowships covered complex adult spine, deformity [...]
View more
Butyrate-producing gut bacteria a promising avenue for Alzheimer’s treatment
Butyrate-producing gut bacteria are a promising target for preventing and treating memory loss associated with Alzheimer’s disease, according to research presented recently at the Alzheimer’s Association International Conference (AAIC) in Amsterdam, Netherlands. The research in […]
View more
Long-term multiple sclerosis treatment: Understanding prognosis, effects and therapies
Early treatment for patients with multiple sclerosis (MS) reduces the number and severity of flare-ups, delays disease progression and is associated with decreased long-term disability from neurological deficits compared with MS patients who did not […]
View more
Adding some separation from the superior cerebellar artery relieves trigeminal neuralgia
The patient A 67-year-old woman presented to clinic with a four-year history of right-sided facial pain. After the onset of her trouble, the pain went into remission for six months. It then recurred, and she […]
View more
The CND Syn-One Test can be used to confirm an initial diagnosis of Parkinson’s disease
Physicians may be able to confirm suspected Parkinson’s disease or other neurological conditions with a skin test. According to the National Institutes of Health, as many as 1 million Americans have Parkinson’s disease, and many […]
View more
Alpha-synuclein skin biopsy reveals early/prodromal Parkinson’s in 61-year-old patient
The patient A 61-year-old male, who is a practicing physician, presented with concerns over his mobility raised by fellow physicians and golf partners. The patient reported that he has always been “stiff” but that perhaps [...]
View more
Making a difference for memory care patients
Kenneth Gregory Pugh, M.D., did not choose to become a memory specialist because it was easy. He was attracted by the intellectual challenge posed by patients with complex issues. Taking the time to properly care […]
View more
Keeping up with treatment and exams can postpone an MS relapse
Monitoring multiple sclerosis (MS) for treatment options through regular visits to an MS specialist can postpone relapses and improve quality of life. “MS is a complicated disease that affects each patient differently. By seeing patients [...]
View more